A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Carboxymethylcellulose Sodium; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• Current use of an artificial tear product

• Visual Acuity of at least 20/40 (while wearing glasses, if necessary).

Exclusion Criteria:

• Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study

• Cataract surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy within 6 months

• Use of RESTASIS® Cyclosporine Ophthalmic Emulsion or any topical cyclosporine within 3 months

• Diagnosis of glaucoma.